OMED

OncoMed Pharmaceuticals, Inc. News Headlines

$21.8
*  
0.37
1.67%
Get OMED Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading OMED now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OMED After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
5 Things Celgene Corporation's Management Wants You to Know
11/5/2014 7:51:02 AM - Motley Fool


Can Celgene Corporation Stock Motor to $150 Following Earnings?
10/28/2014 7:03:08 AM - Motley Fool


Is It Time To Consider OncoMed Pharmaceuticals Again?
10/14/2014 11:09:00 AM - Seeking Alpha


OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape
9/23/2014 7:51:00 AM - Zacks.com


These 7 States Have the Highest Rates of Pancreatic Cancer
9/13/2014 11:17:03 AM - Motley Fool


OncoMed's Shares Gain on Lifting of Partial Clinical Hold - Analyst Blog
9/8/2014 5:00:00 PM - Zacks.com


OncoMed Pharm. To Present Morgan Stanley Conference;Webcast At 11:05 AM ET
9/8/2014 10:00:00 AM - RTT News


REPH Implodes, MRK's Keytruda Gets FDA Nod, New Entrant In Ebola Drug Study
9/5/2014 12:06:00 AM - RTT News


OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog
8/29/2014 4:50:00 PM - Zacks.com


OncoMed Pharmaceuticals (OMED) in Focus: Stock Up 9.9% - Tale of the Tape
8/29/2014 7:51:00 AM - Zacks.com


OncoMed: FDA Removes Clinical Hold On Enrollment In Vantictumab Phase 1 Trials
8/28/2014 8:38:00 AM - RTT News


OncoMed Pharmaceuticals (OMED) in Focus: Stock Rises 5.1% - Tale of the Tape
8/25/2014 7:51:00 AM - Zacks.com


InsiderInsights.com Daily Round Up 8/21/14: RSG, PDI, OPK, TJX
8/22/2014 12:09:00 AM - Seeking Alpha


OncoMed Pharmaceuticals Slumps: OMED Plunges 10.2% in Session - Tale of the Tape
8/12/2014 7:48:00 AM - Zacks.com


Commit To Buy OncoMed Pharmaceuticals At $17.50, Earn 24.7% Annualized Using Options
8/4/2014 10:27:42 AM - BNK Invest


OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 2:50:00 PM - Zacks.com


OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog
6/16/2014 4:22:00 PM - Zacks.com


OncoMed Pharmaceuticals (OMED) Falls: Stock Tumbles 8.8% - Tale of the Tape
6/16/2014 7:47:00 AM - Zacks.com


Friday Sector Laggards: Biotechnology, Drugs
6/13/2014 10:53:18 AM - BNK Invest


Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog
4/24/2014 12:27:01 PM - Zacks.com


Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia


OncoMed's Q4 Loss Narrows - Analyst Blog
3/20/2014 1:50:01 PM - Zacks.com


OncoMed Commences Study on OMP-54F28 - Analyst Blog
2/21/2014 4:50:01 PM - Zacks.com


Ram Selvaraju: A Pair Of Companies Ride The Sea Change In Cancer Therapeutics
2/7/2014 2:22:00 PM - Seeking Alpha


Cramer's Mad Money - It's All About Icahn (1/23/14)
1/24/2014 5:56:00 AM - Seeking Alpha